EUVIMEDEUVIMED entdecken
Crossref

Platelet-Derived Factors Enhance Hepatic Endothelial Fenestration and Reduce Early Metabolic Liver Disease

Maxime Borret, Marie Bellio, Alicia Vauclard, Mathilde Miquel, Claire Congnet, Arnaud Polizzi, Gaëtan Chicanne, Emma Lefrancais, Elodie Riant, Isabelle Fourquaux, Anne Abot, Claude Knauf und 13 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 19.11.2026

DOI: 10.1161/atvbaha.125.323653 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, online erschienen am 19.11.2026. Verfasst von Maxime Borret und 24 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although studies have highlighted the impact of antiplatelet therapies on metabolic dysfunction-associated steatotic liver disease (MASLD), how platelets are involved in liver metabolic dysregulation, especially in the initiation of the disease and its early progression, still remains ill-defined. METHODS: We used nutritional preclinical murine models that exhibit steatosis and early metabolic dysfunction-associated steatohepatitis combined with genetic or pharmacological approaches to modulate platelet count and activation. RESULTS: Our study is the first to reveal a protective role for blood platelets in maintaining liver homeostasis during the early stages of MASLD. We demonstrate that platelets safeguard the liver microenvironment by mitigating 2 key pathological features of early MASLD, lipid accumulation, and inflammation. Platelets accumulate in liver sinusoidal microvessels under steatosis and metabolic dysfunction-associated steatohepatitis, and ameliorate these disease stages by promoting hepatic vascular permeability and enhancing the fenestration of liver sinusoidal microvessels. Critically, we identify that platelets directly regulate liver sinusoidal endothelial cell activation and fenestration, a vital component of liver microvascular function. Mechanistically, this protective effect is mediated through platelet releasate, which increases liver sinusoidal endothelial cell fenestration via an autocrine nitric oxide-dependent signaling pathway. CONCLUSIONS: This study uncovers a novel protective role of platelets in the early stages of MASLD by modulating the phenotype of liver sinusoidal endothelial cells and preserving microvascular integrity through their releasate. These findings challenge the prevailing view of platelets as solely detrimental in MASLD and raise important considerations for the timing of antiplatelet therapies in MASLD management.

Zitieren

APA

Borret, M., Bellio, M., Vauclard, A., Miquel, M., Congnet, C., Polizzi, A., Chicanne, G., Lefrancais, E., Riant, E., Fourquaux, I., Abot, A., Knauf, C., Pieruccioni, L., Vigneau, M., Fellmann, M., Angénieux, C., Maitre, B., Briand, F., Sulpice, T., …, & Severin, S. (2026). Platelet-Derived Factors Enhance Hepatic Endothelial Fenestration and Reduce Early Metabolic Liver Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.323653

Vancouver

Borret M, Bellio M, Vauclard A, Miquel M, Congnet C, Polizzi A, et al. Platelet-Derived Factors Enhance Hepatic Endothelial Fenestration and Reduce Early Metabolic Liver Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.125.323653

BibTeX
@article{Borret2026,
  author = {Borret, Maxime and Bellio, Marie and Vauclard, Alicia and Miquel, Mathilde and Congnet, Claire and Polizzi, Arnaud and Chicanne, Gaëtan and Lefrancais, Emma and Riant, Elodie and Fourquaux, Isabelle and Abot, Anne and Knauf, Claude and Pieruccioni, Laetitia and Vigneau, Mathieu and Fellmann, Marine and Angénieux, Catherine and Maitre, Blandine and Briand, François and Sulpice, Thierry and Gamet-Payrastre, Laurence and Valet, Philippe and Guillou, Hervé and Pradère, Jean-Philippe and Payrastre, Bernard and Severin, Sonia},
  title = {Platelet-Derived Factors Enhance Hepatic Endothelial Fenestration and Reduce Early Metabolic Liver Disease},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  doi = {10.1161/atvbaha.125.323653}
}
Kostenlos starten →